pdufa.bio
HomeDecisions › JAGX 2026-04-29

JAGX FDA decision — Apr 29, 2026

✓ APPROVED

Jaguar Health Inc. — Canalevia-CA1 · Chemotherapy-induced diarrhea (CID) in dogs.

Run-up into the decision (T-120 → T+5)

PDUFA 4/29/26$63.175$8.43511/12/25
Daily close, T-120 (11/12/25) through T+5. Run-up high $63.175 on 11/25/25, low $8.435 on 4/28/26 (T-120 to T-1). FDA decision 4/29/26. Historical price action, not a forecast.

Key facts

FDA decision date2026-04-29
OutcomeApproved
Drug / candidateCanalevia-CA1
CompanyJaguar Health Inc.
120-day run-up (T-120→T-1)-85.7%